Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.
Using RFLP, the present study sets off to determine the MHC class II gene polymorphism in Graves' disease, in order to define the HLA-related genetic susceptibility. Considering the preferential link between Graves' disease and the HLA-DR3 antigen, 42 HLA-DR3 Graves' disease patients were studied and compared with 42 HLA-DR-matched controls. Hybridization with a DQ alpha probe of DNAs digested by Taq I revealed a polymorphism of the DR3 haplotype with an overrepresentation of a 2.1 kb(U) fragment in patients, but this was merely a sign of the linkage disequilibrium between U and B8DR3. Hybridization with the DR beta probe of DNAs digested by Taq I yielded more facts. It revealed the overrepresentation of the Dw24 specificity (Taq I:9.8 kb) in DR3 Graves' disease patients. This study thus enabled us to determine precisely the susceptibility linked to the DR3 haplotype, implicating the DRB3 gene and its Dw24 allele, which appear to be the most reliable markers of the disease, providing a higher relative risk than B8DR3.
Semana
G
G
Laboratoire d'Histocompatibilité, Centre Regional de Transfusion Sanguine, Rennes, France.
Allanic
H
H
Quillivic
F
F
Vallejo
M T
MT
Simon
J P
JP
Genetet
B
B
Fauchet
R
R
D000483:Alleles; D001327:Autoimmune Diseases / Q000235:genetics*; D015252:Deoxyribonucleases, Type II Site-Specific; D004198:Disease Susceptibility; D005787:Gene Frequency; D005802:Genes, MHC Class II; D005838:Genotype; D006111:Graves Disease / Q000235:genetics*; D006683:HLA-DQ Antigens / Q000235:genetics; D006684:HLA-DR Antigens / Q000235:genetics*; D059810:HLA-DR Serological Subtypes; D006801:Humans; D010641:Phenotype; D012150:Polymorphism, Restriction Fragment Length; D012307:Risk Factors
D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D059810:HLA-DR Serological Subtypes; C051104:HLA-DR52 antigen; D015252:Deoxyribonucleases, Type II Site-Specific; C027046:TCGA-specific type II deoxyribonucleases